Novel Coronavirus-Induced NLRP3 Inflammasome Activation: A Potential Drug Target in the Treatment of COVID-19

Overview of attention for article published in Frontiers in immunology, May 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news: 1 news outlet
twitter: 26 X users

patent: 3 patents

Citations

dimensions_citation: 153 Dimensions

Readers on

mendeley: 195 Mendeley

Summary News X Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

ANTIVIRAL COMPOSITION FOR SARS-COV-2 AND HCOV-OC43 COMPRISING RHEIN, MECLOFENAMIC ACID…

Application WO-2022107999-A1

World Intellectual Property Organisation (WIPO)

MODULATORS OF PURINERGIC RECEPTORS AND RELATED IMMUNE CHECKPOINT FOR TREATING ACUTE…

Application WO-2021245107-A3

World Intellectual Property Organisation (WIPO)

METHODS AND COMPOSITIONS FOR TREATMENT OF SARS-COV-2 INFECTION

Application WO-2021198511-A1

World Intellectual Property Organisation (WIPO)